Johnson K, Bertoli M, Phillips L, et al. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness. Skelet Muscle. 2018;8(1):23. doi:10.1186/s13395-018-0170-1.

Arruda AP, Pers BM, Parlakgul G, et al. Defective STIM-mediated store operated Ca entry in hepatocytes leads to metabolic dysfunction in obesity. Elife. 2017;6. doi:10.7554/eLife.29968.

Campa C, Vetere A, Gamini A, Donati I, Paoletti S. Enzymatic synthesis and characterization of oligosaccharides structurally related to the repeating unit of Pullulan. Biochem Biophys Res Commun. 2002;297(2):382-9.

Vetere A, Gamini A, Campa C, Paoletti S. Regiospecific transglycolytic synthesis and structural characterization of 6-O-alpha-glucopyranosyl-glucopyranose (isomaltose). Biochem Biophys Res Commun. 2000;274(1):99-104. doi:10.1006/bbrc.2000.3068.

Vetere A, Miletich M, Bosco M, Paoletti S. Regiospecific glycosidase-assisted synthesis of lacto-N-biose I (Galbeta1-3GlcNAc) and 3’-sialyl-lacto-N-biose I (NeuAcalpha2-3Galbeta1-3GlcNAc). Eur J Biochem. 2000;267(4):942-9.

Vetere A, Bosco M, Paoletti S. Enzymatic synthesis and characterization of 6-O-Beta-D-xylopyranosyl-2-acetamido-2-deoxy-D-glucopyranose, a structural analog of primeverose. Carbohydr Res. 1998;311(1-2):79-83.

Vetere A, Galateo C, Paoletti S. All-aqueous, regiospecific transglycosylation synthesis of 3-O-alpha-L-fucopyranosyl-2-acetamido-2-deoxy-D-glucopyranose, a building block for the synthesis of branched oligosaccharides. Biochem Biophys Res Commun. 1997;234(2):358-61. doi:10.1006/bbrc.1997.6630.

Vetere A, Paoletti S. Complete synthesis of 3’-sialyl-N-acetyllactosamine by regioselective transglycosylation. FEBS Lett. 1996;399(3):203-6.

Urgaonkar S, Shaw JT. Synthesis of kaempferitrin. J Org Chem. 2007;72(12):4582-5. doi:10.1021/jo070502w.

Reiling JH, Clish CB, Carette JE, Varadarajan M, Brummelkamp TR, Sabatini DM. A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin. Proc Natl Acad Sci U S A. 2011;108(29):11756-65. doi:10.1073/pnas.1018098108.